论文信息 - Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer. - 字舞流文

Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer.

O. Lipatov | J. Eckardt | H. Breitz | D. Karlin | F. Mackintosh | I. Polyakov | F. R. Mackintosh | D. Bentsion | G. S. Baker